Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach.

Citation: Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M.: Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach. J Med Chem, Volume 57 (21), 2014
Authors: Kanzaki N, Kori M., Kuno H, Mototani H, Naito T, Nara H, Oki H, Santou T, Sato K, Terauchi J, Uchikawa O, Yamamoto Y
Journal: J Med Chem
Year: 2014
DOI: 10.1021/jm500981k
PubMed: 25264600
Machine-readable: REST API RDF

Publication